The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Katherine Wesseling-Perry

Department of Pediatrics

David Geffen School of Medicine at UCLA

A2-383 MDCC

650 Charles Young Drive

[email]@*.ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pediatrics, David Geffen School of Medicine at UCLA, A2-383 MDCC, 650 Charles Young Drive. 2008 - 2012
  • Correspondence and offprint requests to: Katherine Wesseling-Perry; E-mail:. 2011

References

  1. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Wesseling-Perry, K., Pereira, R.C., Tseng, C.H., Elashoff, R., Zaritsky, J.J., Yadin, O., Sahney, S., Gales, B., Jüppner, H., Salusky, I.B. Clin. J. Am. Soc. Nephrol (2012) [Pubmed]
  2. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Wesseling-Perry, K., Pereira, R.C., Sahney, S., Gales, B., Wang, H.J., Elashoff, R., Jüppner, H., Salusky, I.B. Kidney Int. (2011) [Pubmed]
  3. CKD-MBD after kidney transplantation. Wesseling-Perry, K., Bacchetta, J. Pediatr. Nephrol. (2011) [Pubmed]
  4. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23? Wesseling-Perry, K., Tsai, E.W., Ettenger, R.B., Jüppner, H., Salusky, I.B. Nephrol. Dial. Transplant. (2011) [Pubmed]
  5. FGF-23 in bone biology. Wesseling-Perry, K. Pediatr. Nephrol. (2010) [Pubmed]
  6. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84). Wesseling-Perry, K., Harkins, G.C., Wang, H.J., Elashoff, R., Gales, B., Horwitz, M.J., Stewart, A.F., Jüppner, H., Salusky, I.B. J. Clin. Endocrinol. Metab. (2010) [Pubmed]
  7. Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Wesseling-Perry, K., Harkins, G.C., Wang, H.J., Sahney, S., Gales, B., Elashoff, R.M., Jüppner, H., Salusky, I.B. Pediatr. Nephrol. (2009) [Pubmed]
  8. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. Wesseling-Perry, K., Pereira, R.C., Wang, H., Elashoff, R.M., Sahney, S., Gales, B., Jüppner, H., Salusky, I.B. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  9. Chronic kidney disease mineral and bone disorder in children. Wesseling, K., Bakkaloglu, S., Salusky, I. Pediatr. Nephrol. (2008) [Pubmed]
 
WikiGenes - Universities